All Editorials articles
-
Opinion‘Molecular glues’ are sticking it to cancer
Compounds that enhance selected protein–protein interactions to interfere with signalling or send proteins to be destroyed are making it possible to influence processes that were previously considered ‘undruggable’
-
OpinionDeadly reminders of the importance of risk assessment
Serious incidents in two university labs highlight the importance of knowing what to do when things go wrong
-
OpinionArtificial intelligence or clever artifice?
It’s important to be realistic about what AI can, and can’t, achieve, across the chemistry enterprise
-
OpinionMessy megamergers
Rumoured merger between AstraZeneca and Bristol Myers Squibb has collapsed, and that’s probably a good thing
-
OpinionTrump threatens generic drug tariffs
Plan aims to encourage domestic US supplies, but will it work?
-
OpinionWhere does chemical recycling of plastics go from here?
US and EU plant closures highlight economic difficulties of scaling technology alongside associated policy and infrastructure
-
OpinionIt’s time for consensus on science’s place in government
The latest shake-up of UK science policy oversight brings uncertainty to a sector that needs stability to succeed
-
OpinionTrust is easily broken and hard to rebuild
Thermo Fisher needs to be open and honest about data manipulation to reassure researchers
-
OpinionIs industry getting more or less safe?
US figures suggest an increase in incidents involving serious injuries and fatalities in recent years
-
OpinionShould the EU stop exports of pesticides it has banned?
Agrochemicals including paraquat remain legal elsewhere, prompting questions over regulatory responsibility
-
OpinionGSK agrees $10 billion deal for Nuvalent cancer drugs
Deal includes two late-stage molecules to augment GSK’s renewed cancer therapy pipeline
-
OpinionHow far will EU push for fairer trade with China?
Strengthening rules on pharmaceutical and chemical trade could protect critical industries
-
OpinionBritish Steel’s nationalisation plan contrasts against chemical industry decline
UK steel production has been declining for decades thanks to high costs and cheap imports
-
OpinionIran war’s global impact keeps growing
Shortages of bitumen, cooking gas and jet fuel are pushing up prices and disrupting construction
-
OpinionPurdue Pharma’s opioid prosecution enables bankruptcy settlement
$5 billion criminal sentence paves the way for resolution of civil liabilities through bankruptcy court
-
OpinionMajor drug regulators advancing routes to reduce animal testing
US, UK and EU all have goals to eliminate animal testing
-
OpinionIran ceasefire is the start of a long recovery process
Conflict’s impact on global energy and chemicals supply chains will take significantly longer to resolve
-
OpinionIndia’s generic semaglutide surge
As patents on Novo Nordisk’s diabetes and weight loss blockbusters expire, generic makers have their versions ready
-
OpinionChemical recycling of plastics rises as oil crisis continues
Recovering feedstocks from hard-to-recycle plastic is potentially important in a more circular plastic economy
-
OpinionSharpening chemical intuition
Chemists are moving beyond hand-waving explanations by quantifying factors like the anomeric effect and steric repulsion